Skip to content
lifestyle.ideacrossing.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aclarion, Inc.
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
May 22, 2026
Aclarion Announces $2.5 Million Stock Repurchase Plan
May 21, 2026
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
May 21, 2026
Aclarion Receives Pinnacle Award for AI Innovation
May 20, 2026
Aclarion Announces Agreement with Weill Cornell Medicine
April 29, 2026
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
April 29, 2026
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
March 19, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts
March 19, 2026
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
March 17, 2026
Aclarion CEO Brent Ness to Attend LSI USA 2026
March 12, 2026
1
2
Next Page
→